ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of AMAG Pharmaceuticals, Inc.
NEW YORK, Oct. 2, 2020 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and its board of directors concerning the proposed acquisition of the company by Covis Group S.à.r.l. Stockholders will receive $13.75 for each share of AMAG Pharmaceuticals stock that they hold. The transaction is valued at approximately $647 million and is expected to close in November 2020.
If you are a stockholder of AMAG Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/amag/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
News published on and distributed by:
